[HTML][HTML] Efficacy of salmeterol xinafoate in the treatment of COPD

DA Mahler, JF Donohue, RA Barbee, MD Goldman… - Chest, 1999 - Elsevier
Study objectives To examine and compare the efficacy and safety of salmeterol xinafoate, a
long-acting inhaledβ 2-adrenergic agonist, with inhaled ipratropium bromide and inhaled …

Outcomes and markers in the assessment of chronic obstructive pulmonary disease

PW Jones, AGN Agusti - European Respiratory Journal, 2006 - Eur Respiratory Soc
The clinical presentation of chronic obstructive pulmonary disease (COPD) is highly
variable, reflecting the interaction of a complex range of pathological changes including both …

Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease

DE O'donnell, N Voduc, M Fitzpatrick… - European Respiratory …, 2004 - Eur Respiratory Soc
This study examined the effects of bronchodilator-induced reductions in lung hyperinflation
on breathing pattern, ventilation and dyspnoea during exercise in chronic obstructive …

The 6-min walk distance, peak oxygen uptake, and mortality in COPD

CG Cote, V Pinto-Plata, K Kasprzyk, LJ Dordelly… - Chest, 2007 - Elsevier
In patients with COPD, the maximal oxygen uptake (V˙ o 2) measured at peak exercise and
the 6-min walk distance (6MWD) have been associated with survival; however, no study has …

Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology

PMA Calverley, NG Koulouris - European Respiratory Journal, 2005 - Eur Respiratory Soc
Fashions in ideas, like clothes, come and go. From approximately 1950–1980, physiological
research was seen as the key discipline in understanding lung disease and was at the …

Mechanisms of activity-related dyspnea in pulmonary diseases

DE O'Donnell, J Ora, KA Webb, P Laveneziana… - Respiratory physiology …, 2009 - Elsevier
Progressive activity-related dyspnea dominates the clinical presentation of patients afflicted
by chronic obstructive and restrictive lung diseases. This symptom invariably leads to activity …

Management of chronic obstructive pulmonary disease

ER Sutherland, RM Cherniack - New England Journal of …, 2004 - Mass Medical Soc
The goals of therapy for chronic obstructive pulmonary disease include relieving symptoms,
improving abnormal physiology, and limiting complications, including abnormal gas …

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD

F Maltais, A Hamilton, D Marciniuk, P Hernandez… - Chest, 2005 - Elsevier
Study objectives We have previously shown that tiotropium at 18 μg reduces lung
hyperinflation and dyspnea during exercise and improves exercise tolerance in patients with …

支气管舒张剂和吸入糖皮质激素在慢性阻塞性肺疾病中的应用

姚婉贞, 常春 - 中华结核和呼吸杂志, 2007 - cqvip.com
慢性阻塞性肺疾病(COPD) 是一种慢性呼吸系统疾病, 其主要特征为肺功能的缓慢减退及进行性
气流受限, 气流受限不完全可逆. 通过积极的预防和治疗可以有效缓解症状, 提高运动耐量 …

Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function.

FJ Martinez, MM de Oca, RI Whyte, J Stetz… - American journal of …, 1997 - atsjournals.org
Lung-volume reduction surgery (LVRS) improves static lung elastic recoil in selected
patients with severe chronic obstructive pulmonary disease (COPD). This explains the …